
Precigen, Inc. Common Stock
PGEN Real Time Price USDRecent trades of PGEN by members of U.S. Congress
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
---|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Recently reported changes by institutional investors
Quarterly net insider trading by PGEN's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
Estimated quarterly lobbying spending
PGEN Revenue by Segment or Geography
New patents grants
-
Patent Title: Methods and microorganisms for the fermentation of methane to multi-carbon compounds Feb. 25, 2025
-
Patent Title: Hepatitis b vaccines and uses of the same Feb. 25, 2025
-
Patent Title: Fusion constructs and methods of using thereof Jan. 14, 2025
-
Patent Title: Expression of novel cell tags Dec. 31, 2024
-
Patent Title: Molecular switches Sep. 17, 2024
-
Patent Title: Expression of novel cell tags Aug. 13, 2024
-
Patent Title: Methods and microorganisms for making 1,4-butanediol and derivatives thereof from c1 carbons Jun. 25, 2024
-
Patent Title: Frataxin expression constructs Jun. 04, 2024
-
Patent Title: Muc16 specific chimeric antigen receptors and uses thereof May. 14, 2024
-
Patent Title: Muc16 specific chimeric antigen receptors and uses thereof May. 07, 2024
-
Patent Title: Modulating expression of polypeptides via new gene switch expression systems Apr. 02, 2024
-
Patent Title: Methods and microorganisms for making 2,3-butanediol and derivatives thereof from c1 carbons Mar. 26, 2024
-
Patent Title: Biological production of multi-carbon compounds from methane Nov. 21, 2023
-
Patent Title: Cd33 specific chimeric antigen receptors Oct. 17, 2023
-
Patent Title: Polypeptide compositions comprising spacers Oct. 03, 2023
-
Patent Title: Modulating expression of polypeptides via new gene switch expression systems Jul. 04, 2023
-
Patent Title: Hepatitis b vaccines and uses of the same Mar. 21, 2023
-
Patent Title: Fusion constructs and methods of using thereof Dec. 27, 2022
-
Patent Title: Methods and microorganisms for the fermentation of methane to multi-carbon compounds Aug. 23, 2022
-
Patent Title: Muc16 specific chimeric antigen receptors and uses thereof May. 03, 2022
-
Patent Title: Molecular switches Dec. 14, 2021
-
Patent Title: Methods and microorganisms for making 1,4-butanediol and derivatives thereof from c1 carbons Oct. 26, 2021
-
Patent Title: Compositions and methods for expression of multiple biologically active polypeptides from a single vector for treatment of cardiac conditions and other pathologies Oct. 26, 2021
-
Patent Title: Expression of novel cell tags Sep. 14, 2021
-
Patent Title: Frataxin expression constructs Sep. 14, 2021
-
Patent Title: Methods and microorganisms for making 2,3-butanediol and derivatives thereof from c1 carbons Sep. 07, 2021
-
Patent Title: Expression of novel cell tags Jun. 15, 2021
-
Patent Title: Biological production of multi-carbon compounds from methane Dec. 29, 2020
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to PGEN
Recent picks made for PGEN stock on CNBC
ETFs with the largest estimated holdings in PGEN
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
---|
- Is $PGEN stock a Buy, Sell, or Hold?
- What is the price target for $PGEN stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
Shareholder
|
Shares Held
|
---|
- Who owns $PGEN stock?
- Who owns the most shares of $PGEN stock?
- What funds own $PGEN stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view PGEN Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.